▎ 摘　　要

NOVELTY - Preparing tumor-targeted photothermal responsive controllable drug delivery nanosecond carrier involves reducing graphene oxide to reduced graphene by dopamine, incorporating the porous silica in reduced graphene to form nanocomposites on both sides, and finally absorbing the hyaluronic acid on surface of nanocomposite by electrostatic action. USE - Method used for preparing tumor targeted photothermal responsive controllable drug delivery nanosecond carrier (claimed). ADVANTAGE - The method offers good thermal performance, thus it achieves thermal enhanced type light power treatment as the cancer therapeutic effect of light power.